[1] MA Y L,WANG C Y,GUAN Y J,et al.Long noncoding RNA ROR promotes proliferation and invasion of colorectal cancer by inhibiting tumor suppressor gene NF2 through interacting with miR-223-3p[J].Eur Rev Med Pharmacol Sci,2020,24(5):2401-2411.
[2] EKATERINA C,NATALIA B,PETER K.Kinases of eIF2a switch translation of mRNA subset during neuronal plasticity[J].Int J Mol Sci,2017,18(10):2213-2239.
[3] KOROMILAS A E.Roles of the translation initiation factor eIF2α serine 51 phosphorylation in cancer formation and treatment[J].Biochim Biophys Acta,2015,1849(7):871-880.
[4] LIU J,KE F,CHEN T,et al.MicroRNAs that regulate PTEN as potential biomarkers in colorectal cancer:a systematic review[J].J Cancer Res Clin Oncol,2020,146(4):809-820.
[5] MONTERDE-CRUZ L,RAMIREZ-SALAZAR E G,RICO-MARTINEZ G,et al.Circulating miR-215-5p and miR-642a-5p as potential biomarker for diagnosis of osteosarcoma in Mexican population[J].Hum Cell,2018,31(4):292-299.
[6] 蒋林哲,王月华,王立波,等.实时荧光定量PCR检测结肠癌中HER-2和TOPOⅡα mRNA的表达[J].现代医学,2020,48(1):26-30.
[7] LI Y,CHEN Z.The oncogenic role of microRNA-500a in colorectal cancer[J].Oncol Lett,2020,19(3):1799-1805.
[8] VYCHYTILOVA-FALTEJSKOVA P,MERHAUTOVA J,MACHACKOVA T,et al.MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9[J].Oncogenesis,2017,6(11):399-400.
[9] LIU S,ZHANG Y,HUANG C,et al.miR-215-5p is an anticancer gene in multiple myeloma by targeting RUNX1 and deactivating the PI3K/AKT/mTOR pathway[J].J Cell Biochem,2020,121(2):1475-1490.
[10] ROZPEDEK W,PYTEL D,MUCHA B,et al.The role of the PERK/eIF2α/ATF4/CHOP signaling pathway in tumor progression during endoplasmic reticulum stress[J].Curr Mol Med,2016,16(6):533-544.
[11] TANAKA I,SATO M,KATO T,et al.eIF2β,a subunit of translation-initiation factor EIF2,is a potential therapeutic target for non-small cell lung cancer[J].Cancer Sci,2018,109(6):1843-1852.
[12] KIM J Y,HEO S H,SONG I H,et al.Activation of the PERK-eIF2α pathway is associated with tumor-infiltrating lymphocytes in HER2-positive breast cancer[J].Anticancer Res,2016,36(6):2705-2711.
[13] BURWICK N,AKTAS B H.The eIF2-alpha kinase HRI:a potential target beyond the red blood cell[J].Expert Opin Ther Targets,2017,21(12):1171-1177.
[14] REN W,LI Y,XIA X,et al.Arginine inhibits the malignant transformation induced by interferon-gamma through the NF-κB-GCN2/eIF2α signaling pathway in mammary epithelial cells in vitro and in vivo[J].Exper Cell Res,2018,15(7):236-247.
[15] BRUNELLI C,AMICI C,ANGELINI M,et al.The non-steroidal anti-inflammatory drug indomethacin activates the eIF2α kinase PKR,causing a translational block in human colorectal cancer cells[J].Biochem J,2012,443(2):379-386.
[16] SINGH A,BHATTACHARYYA N,SRIVASTAVA A,et al.MicroRNA-215-5p treatment suppresses mesothelioma progression via the MDM2-p53-signaling axis[J].Mol Ther,2019,27(9):1665-1680.
[17] CAI J,YANG J,LIU Q,et al.Selenium deficiency inhibits myocardial development and differentiation by targeting the mir-215-5p/CTCF axis in chicken[J].Metallomics,2019, 11(2):415-428.
[18] GAO J B,ZHU M N,ZHU X L.miRNA-215-5p suppresses the aggressiveness of breast cancer cells by targeting Sox9[J].FEBS Open Bio,2019,9(11):1957-1967.
[19] WANG S F,CHEN M S,CHOU Y C,et al.Mitochondrial dysfunction enhances cisplatin resistance in human gastric cancer cells via the ROS-activated GCN2-eIF2α-ATF4-xCT pathway[J].Oncotarget,2016,7(45):74132-74151.
[20] PODSZYWALOW-BARTNICKA P,CMOCH A,WOLCZYK M,et al.Increased phosphorylation of eIF2α in chronic myeloid leukemia cells stimulates secretion of matrix modifying enzymes[J].Oncotarget,2016,7(48):79706-79721.
[21] JU S M,JO Y S,JEON Y M,et al.Phosphorylation of eIF2α suppresses cisplatin-induced p53 activation and apoptosis by attenuating oxidative stress via ATF4-mediated HO-1 expression in human renal proximal tubular cells[J].Int J Mol Med,2017,40(6):1957-1964. |